Overview

The Repatriation Medical Authority Instrument No. 65 of 2011, made under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, addresses the need to update the criteria for assessing malignant neoplasm of the stomach in relation to veterans' entitlements. This legislative instrument was enacted to refine the assessment process by modifying the factors and definitions associated with the condition, specifically replacing and removing certain factors concerning ionising radiation and its dosages. This revision aims to ensure that the criteria for entitlement remain relevant and accurately reflect current medical understanding and evidence. The Authority, having advertised its intention to investigate this matter and invited submissions without receiving any, finalised the investigation through this instrument, specifying its effective date in accordance with the Legislative Instruments Act 2003. This amendment seeks to provide clarity and fairness in the adjudication of claims related to this condition among veterans.

Scope and Application

The Repatriation Medical Authority Instrument No. 65 of 2011 amends Statement of Principles Instrument No. 7 of 2003 concerning malignant neoplasm of the stomach under the Veterans’ Entitlements Act 1986. This legislative instrument applies to veterans who have served in the Australian Defence Force and are seeking benefits or compensation related to malignant neoplasm of the stomach. The amendments include replacing existing factors related to the condition with new factors concerning ionising radiation, deleting certain definitions, and specifying a date of effect for the changes in accordance with the Legislative Instruments Act 2003. The Authority undertook an investigation into the matter, advertised its intention in the Government Notices Gazettes, and invited submissions from relevant parties, though no submissions were received. This Instrument finalises the investigation and outlines a process for requesting references relating to the condition from the Repatriation Medical Authority. The instrument operates within the Commonwealth jurisdiction and extends its application through subordinate instruments as specified.

Key Provisions

The Repatriation Medical Authority Instrument No. 65 of 2011 amends Statement of Principles Instrument No. 7 of 2003, addressing malignant neoplasm of the stomach. This legislative instrument introduces several significant changes. Firstly, it replaces existing factor 5(a)(ii) with a new factor concerning "ionising radiation" and removes factor 5(a)(iii) as it is now encompassed within the new factor 5(a)(ii). Additionally, the instrument revises the definition of "cumulative equivalent dose" in clause 8 and eliminates the definitions of "a course of therapeutic radiation" and "atomic radiation" from the same clause. These amendments are designed to refine and update the criteria under which claims related to malignant neoplasm of the stomach are assessed, particularly in relation to exposure to ionising radiation. The obligations imposed by this Instrument are primarily on the Repatriation Medical Authority, which is tasked with ensuring that the amendments are effectively implemented and that all relevant stakeholders are informed. The Authority is also required to maintain records of the investigation and any submissions received, even if none were submitted for this particular Instrument. Furthermore, the Authority must ensure that the new definitions and factors are accurately applied in all future assessments and decisions related to veterans’ entitlements for malignant neoplasm of the stomach. Non-compliance with the provisions of this Instrument could result in legal consequences for the Authority, although no specific offences or penalties are outlined in the document. However, the authority's failure to correctly apply the new criteria could lead to disputes and appeals by affected parties, potentially resulting in judicial review. The consequences for veterans or claimants might include delays in the processing of their claims or incorrect assessments, which could be rectified through the appeal process or by seeking legal advice. The Instrument also ensures transparency and accessibility of the legislative changes. It specifies a date of effect in accordance with the Legislative Instruments Act 2003, ensuring that the amendments come into force at a designated time. Additionally, it provides a list of references related to the condition, available to specified persons or organisations upon written request. This ensures that all relevant parties have access to the information needed to understand and comply with the new legislative requirements.